- Home
- VRDN vs CLM Comparison
VRDN vs CLM Comparison
Compare VRDN & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRDN | CLM |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VRDN | CLM |
|---|---|---|
| Price | $23.03 | $6.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $35.46 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 2.3M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $13.73 | N/A |
| Revenue Next Year | $279.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.18 | $6.57 |
| 52 Week High | $34.29 | $8.53 |
Technical Indicators
Market Signals| Indicator | VRDN | CLM |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 25.45 |
| Support Level | $21.62 | N/A |
| Resistance Level | $24.86 | $7.73 |
| Average True Range (ATR) | 0.77 | 0.10 |
| MACD | -0.23 | -0.04 |
| Stochastic Oscillator | 43.52 | 0.75 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, Consumer Staples, utilities, energy, Real Estate, materials, and other sectors.